Mechanisms responsible for surfactant changes in sepsis-induced lung injury

European Respiratory Journal

Volumn 26, Issue 6, 2005, Pages 1074-1079

  Huang, W ^a   McCaig, L A ^a   Veldhuizen, R A W ^a   Yao, L J ^a   Lewis, J F ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Lung injury; Sepsis; Surfactant

Indexed keywords

DIPALMITOYLPHOSPHATIDYLCHOLINE; LUNG SURFACTANT; TRITIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; LUNG ALVEOLUS MACROPHAGE; LUNG INJURY; MALE; NONHUMAN; PERFORATION; PRIORITY JOURNAL; RADIOACTIVITY; RAT; SEPSIS;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; ANALYSIS OF VARIANCE; ANIMALS; DISEASE MODELS, ANIMAL; LIPID METABOLISM; LUNG DISEASES; MACROPHAGES; MALE; PROBABILITY; PULMONARY SURFACTANT-ASSOCIATED PROTEINS; PULMONARY SURFACTANTS; RATS; RATS, SPRAGUE-DAWLEY; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEPSIS;

EID: 29244464799     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.05.00085805     Document Type: Article

References (27)

1. Goerke J. Pulmonary surfactant: functions and molecular composition. Biochim Biophys Acta 1998; 1408: 79-89.
2. Lewis JF, Jobe AH. Surfactant and the adult respiratory distress syndrome. Am Rev Respir Dis 1993; 147: 218-233.
3. Veldhuizen RA, McCaig LA, Akino T, Lewis JF. Pulmonary surfactant subfractions in patients with the acute respiratory distress syndrome. Am J Respir Crit Care Med 1995; 152: 1867-1871.
4. Pison U, Obertacke U, Brand M, et al. Altered pulmonary surfactant in uncomplicated and septicemia-complicated courses of acute respiratory failure. J Trauma 1990; 30: 19-26.
5. Gunther A, Siebert C, Schmidt R. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med 1996; 153: 176-184.
6. Gregory TJ, Longmore WJ, Moxley MA. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 1991; 88: 1976-1981.
7. Gregory TJ, Steinberg KP, Spragg R. Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1997; 155: 1309-1315.
8. Spragg RG, Gilliard N, Richman P. Acute effects of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome. Chest 1994; 105: 195-202.
9. Anzueto A, Baughman RP, Guntupalli KK. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. N Engl J Med 1996; 334: 1417-1421.
10. Malloy J, McCaig L, Veldhuizen R. Alterations of the endogenous surfactant system in septic adult rats. Am J Respir Crit Care Med 1997; 156: 617-623.
11. Putman E, Boere AJF, Van Bree L, Van Golde LMG, Haagsman HP. Pulmonary surfactant subtype metabolism is altered after short-term ozone exposure. Toxicol Appl Pharmacol 1995; 134: 132-138.
12. Mander A, Langton-Hewer S, Bernhard W, Warner JO, Postle AD. Altered phospholipid composition and aggregate structure of lung surfactant is associated with impaired lung function in young children with respiratory infections. Am J Respir Cell Mol Biol 2002; 27: 714-721.
13. Gross NJ. Extracellular metabolism of pulmonary surfactant: the role of a new serine protease. Annu Rev Physiol 1995; 57: 135-150.
14. Lewis JF, Ikegami M, Jobe AH. Altered surfactant function and metabolism in rabbits with acute lung injury. J Appl Physiol 1990; 69: 2303-2310.
15. Malloy J, Veldhuizen RAW, McCormack FX, Korfhagen T, Whitseft J, Lewis J. Pulmonary surfactant and inflammation in septic adult mice: role of surfactant protein A. J Appl Physiol 2002; 92: 809-816.
16. Bailey TC, Cavanagh C, Mehta S, Lewis JF, Veldhuizen RA. Sepsis and hyperoxia effects on the pulmonary surfactant system in wild-type and iNOS knockout mice. Eur Respir J 2002; 20: 177-182.
17. Veldhuizen RAW, Marcou J, Yao L-J, McCaig L, Ito Y, Lewis JF. Alveolar surfactant aggregate conversion in ventilated normal and injured rabbits. Am Physiol 1996; 270: L152-L158.
18. Gross NJ, Narine KR. Surfactant subtypes of mice: metabolic relationships and conversion in vitro. J Appl Physiol 1989; 67: 414-421.
19. Duck-Chong CG. A rapid sensitive method for determining phospholipid phosphorus involving digestion with magnesium nitrate. Lipids 1979; 14: 492-497.
20. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37: 911-917.
21. Abel SJ, Finney SJ, Brett SJ, Keogh BF, Morgan CJ, Evans TW. Reduced mortality in association with the acute respiratory distress syndrome (ards). Thorax 1998; 53: 292-294.
22. Montgomery AB, Stager MA, Carrico CJ, Hudson ED. Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1985; 132: 485-489.
23. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29: 1303-1310.
24. Livingston DH, Mosenthal AC, Deitch EA. Sepsis and multiple organ dysfunction syndrome: a clinical-mechanistic overview. New Horiz 1995; 3: 257-266.
25. Dranoff G, Crawford AD, Sadelain M. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 1994; 264: 713-716.
26. Reed JA, Ikegami M, Cianciolo ER. Aerosolized GM-CSF ameliorates pulmonary alveolar proteinosis in GM-CSF-deficient mice. Am J Physiol 1999; 276: L556-L563.
27. Wright JR, Hawgood S. Pulmonary surfactant metabolism. Clin Chest Med 1989; 10: 83-93.